{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:50:00Z","timestamp":1793191800185,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejmech.2020.112793","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T18:18:36Z","timestamp":1599416316000},"page":"112793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors"],"prefix":"10.1016","volume":"206","author":[{"given":"Ziyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9992-5956","authenticated-orcid":false,"given":"Zizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-7905","authenticated-orcid":false,"given":"Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-5007","authenticated-orcid":false,"given":"Huihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112793_bib1","doi-asserted-by":"crossref","first-page":"10809","DOI":"10.1073\/pnas.91.23.10809","article-title":"Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors","volume":"91","author":"Song","year":"1994","journal-title":"P.\u00a0Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2020.112793_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2020.112793_bib3","first-page":"7025","article-title":"A\u00a0novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid\/thyroid hormone receptor subfamily","volume":"14","author":"Apfel","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2020.112793_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tips.2012.03.013","article-title":"Liver X receptor biology and pharmacology: new pathways, challenges and opportunities","volume":"33","author":"Jakobsson","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2020.112793_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2020.112793_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.07.010","article-title":"The challenges and promise of targeting the liver X receptors for treatment of inflammatory disease","volume":"181","author":"Fessler","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2020.112793_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2006.11.022","article-title":"Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma","volume":"25","author":"Ghisletti","year":"2007","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2020.112793_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1101\/gad.545110","article-title":"GPS2-dependent corepressor\/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response","volume":"24","author":"Venteclef","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2020.112793_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm4074","article-title":"Transcriptional regulation of hepatic lipogenesis","volume":"16","author":"Wang","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2020.112793_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cb300541g","article-title":"A\u00a0liver-selective LXR inverse agonist that suppresses hepatic steatosis","volume":"8","author":"Griffett","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112793_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","article-title":"The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis","volume":"4","author":"Griffett","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ejmech.2020.112793_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","article-title":"Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis","volume":"28","author":"Flaveny","year":"2015","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2020.112793_bib13","doi-asserted-by":"crossref","first-page":"8071093","DOI":"10.1155\/2018\/8071093","article-title":"Liver X receptor inverse agonist SR9243 suppresses nonalcoholic steatohepatitis intrahepatic inflammation and fibrosis","volume":"2018","author":"Huang","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2020.112793_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.bbalip.2015.09.007","article-title":"Destabilization of the torsioned conformation of a ligand side chain inverts the LXRbeta activity","volume":"1851","author":"\u00c1lvarez","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2020.112793_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jsbmb.2016.07.001","article-title":"Fluorinated oxysterol analogues: synthesis, molecular modelling and LXRbeta activity","volume":"165","author":"Rodriguez","year":"2017","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112793_bib16","doi-asserted-by":"crossref","first-page":"105585","DOI":"10.1016\/j.jsbmb.2020.105585","article-title":"Cholestenoic acid analogues as inverse agonists of the liver X receptors","volume":"199","author":"Alvarez","year":"2020","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112793_bib17","doi-asserted-by":"crossref","first-page":"112240","DOI":"10.1016\/j.ejmech.2020.112240","article-title":"Discovery of new LXR\u03b2 agonists as glioblastoma inhibitors","volume":"194","author":"Chen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112793_bib18","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/ja983788i","article-title":"Total synthesis of Spirotryprostatin A, leading to the discovery of some biologically promising analogues","volume":"121","author":"Edmondson","year":"1999","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112793_bib19","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jo1002714","article-title":"Tandem intramolecular photocycloaddition-retro-Mannich fragmentation as a route to spiro[pyrrolidine-3,3\u2019-oxindoles]. Total synthesis of (+\/-)-coerulescine, (+\/-)-horsfiline, (+\/-)-elacomine, and (+\/-)-6-deoxyelacomine","volume":"75","author":"White","year":"2010","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112793_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejmech.2019.06.011","article-title":"Identify liver X receptor beta modulator building blocks by developing a fluorescence polarization-based competition assay","volume":"178","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112793_bib21","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/acs.jcim.9b00292","article-title":"Structurally selective mechanism of liver X receptor ligand: in silico and in\u00a0vitro studies","volume":"59","author":"Ding","year":"2019","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2020.112793_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/pr.112.006833","article-title":"Nuclear receptors and their selective pharmacologic modulators","volume":"65","author":"Burris","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2020.112793_bib23","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/ncomms2924","article-title":"The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism","volume":"4","author":"Jin","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.112793_bib24","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1038\/s41467-019-10853-2","article-title":"Molecular tuning of farnesoid X receptor partial agonism","volume":"10","author":"Merk","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.112793_bib25","series-title":"Gaussian 09W","author":"Frisch","year":"2009"},{"key":"10.1016\/j.ejmech.2020.112793_bib26","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/ci100511v","article-title":"Three-dimensional pharmacophore modeling of liver-X receptor agonists","volume":"51","author":"Zhao","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2020.112793_bib27","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112793_bib28","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2020.112793_bib29","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/ct200909j","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. generalized Born","volume":"8","author":"G\u00f6tz","year":"2012","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2020.112793_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2020.112793_bib31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2020.112793_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.bcp.2012.07.003","article-title":"Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds","volume":"84","author":"Zeng","year":"2012","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420307650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420307650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:17:30Z","timestamp":1759328250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420307650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":32,"alternative-id":["S0223523420307650"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112793","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112793"}}